MedTrace Logo

Diagnosing Respiratory Disease in Children Using Cough Sounds

NCT02973282 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1245

Last updated 2018-01-05

No results posted yet for this study

Summary

The purpose of this prospective study is to evaluate the efficacy of the ResAppDx software application in diagnosis of pneumonia and other respiratory conditions (bronchiolitis, asthma/reactive airway disease, croup, upper or lower respiratory tract infections) in infants and children. Patient's cough sounds will be recorded using a smartphone and analysed using the ResAppDx software. The ResAppDx diagnosis will be compared to radiologic diagnosis and/or clinical diagnosis. The ResAppDx diagnosis will not be provided to the clinician or patient.

Conditions

Interventions

OTHER

Recording of Infants and Children's Cough Sounds

Smartphone recordings of the cough sounds of infants and children presenting to a participating site with signs or symptoms of respiratory disease

Sponsors & Collaborators

  • Massachusetts General Hospital

    collaborator OTHER

  • The Cleveland Clinic

    collaborator OTHER

  • Baylor College of Medicine

    collaborator OTHER

  • ResApp Health Limited

    lead INDUSTRY

Principal Investigators

  • Peter P Moschovis, MD, MPH · Massachusetts General Hospital

Eligibility

Min Age
29 Days
Max Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-12-31
Primary Completion
2017-12-31
Completion
2017-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02973282 on ClinicalTrials.gov